Kerri Fitzgerald

DocwireNews

<a href="https://www.docwirenews.com/docwire-pick/nasopharyngeal-carcinoma-patients/">Insomnia is common in cancer survivors</a>, and a recent study published in Sleep Medicine found that approximately half of patients with cancer have symptoms of insomnia that may persist for up to a year after treatment. Insomnia is particularly prevalent in women.The longitudinal, multicenter German study included 405 patients with cancer, 56% of whom were female (mean age, 58.6 years). Researchers used the Insomnia Severity Index (ISI) to measure cancer-related insomnia. They also assessed sociodemographic and clinical data and psychological parameters at baseline and at 12 months.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
The course of cancer-related insomnia: don&rsquo;t expect it to disappear after cancer treatment <a href="https://t.co/j9P9fypwJI">https://t.co/j9P9fypwJI</a>
&mdash; Dr. Sheila Garland (@SNGarlandPhD) <a href="https://twitter.com/SNGarlandPhD/status/1106361334537641985?ref_src=twsrc%5Etfw">March 15, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Half of patients experiencing insomniaThe prevalence of <a href="https://www.docwirenews.com/docwire-pick/early-risers-lower-breast-cancer/">insomnia symptoms</a> was high: 49.4% of participants had symptoms of insomnia (ISI &gt;7), and 12.8% had a verified clinical diagnosis of insomnia (ISI &gt;14). Among those who had insomnia at baseline, this persisted after one year in 64% of patients. At 12 months, significantly more women suffered from insomnia symptoms than men (53.3% vs. 39.3%; P=0.003).Factors associated with insomniaInsomnia was associated with many clinical and psychological parameters, particularly fatigue (r=0.5). In women, only insomnia at baseline was a significant predictor of insomnia at 12 months (P&lt;0.001), whereas in men insomnia, depressive symptoms, and the use of psychotropic drugs at baseline were predictive of insomnia at 12 months (P&lt;0.001). In men and women, levels of distress, depression, and anxiety decreased from baseline to 12 months (P&lt;0.016 for all).&ldquo;Adequate support for those affected [by insomnia] is needed,&rdquo; the authors concluded.

Jordana Jampel

Brensocatib Shows Positive Results for Managing Bronchiectasis Symptoms

Pulmonology

Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Latest News

Impact of Insomnia on Cancer Survivors, Particularly in Women

Oncology

Insomnia is common in cancer survivors, and a recent study published in Sleep Medicine found that approximately half of patients with cancer have symptoms of insomnia that may ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe